Intangible Assets and Goodwill

3 Months Ended

Mar. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2013. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner if warranted as was the case for certain indefinite lived assets in the fiscal first quarter of 2014.



(Dollars in Millions)	March 30, 2014		December 29, 2013
Intangible assets with definite lives:
Patents and trademarks — gross	$	9,190	9,164
Less accumulated amortization	4,291		4,146
Patents and trademarks — net	4,899		5,018
Customer relationships and other intangibles — gross	18,809		19,027
Less accumulated amortization	4,833		4,872
Customer relationships and other intangibles — net	13,976		14,155
Intangible assets with indefinite lives:
Trademarks	7,634		7,619
Purchased in-process research and development	1,134		1,155
Total intangible assets with indefinite lives	8,768		8,774
Total intangible assets — net	$	27,643	27,947

Goodwill as of March 30, 2014 was allocated by segment of business as follows:



(Dollars in Millions)	Consumer			Pharm		Med Dev & Diag			Total
Goodwill, net at December 29, 2013	$	8,531		2,068		12,199			22,798
Acquisitions	—			—		—			—
Currency translation/Other	(19		)	(3	)	(598	)	⁽¹⁾	(620	)
Goodwill, net as of March 30, 2014	$	8,512		2,065		11,601			22,178

⁽¹⁾Includes $604 million classified as held for sale, a component of other assets on the Consolidated Balance Sheet,

related to the pending divestiture of Ortho-Clinical Diagnostics.

The weighted average amortization periods for patents and trademarks and customer relationships and other intangible assets are 17 years and 24 years, respectively. The amortization expense of amortizable intangible assets was $351 million and $335 million for the fiscal first quarters ended March 30, 2014 and March 31, 2013, respectively. The estimated amortization expense for the five succeeding years approximates $1,350 million, before tax, per year. Amortization expense is included in cost of products sold.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details